ClinConnect ClinConnect Logo
Search / Trial NCT05423028

Vitamin B12 and Dextrose for Median Nerve Hydrodissection

Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Jun 14, 2022

Trial Information

Current as of June 06, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different injection treatments can help people with carpal tunnel syndrome, a condition that causes pain and discomfort in the hand and wrist due to pressure on the median nerve. The researchers want to compare the effects of two treatments: one is an injection of dextrose (a type of sugar) mixed with water, and the other is an injection that includes vitamin B12. Previous studies have suggested that these treatments could improve symptoms, but this trial aims to provide more clear results.

To participate in this trial, you need to be between 20 and 80 years old and have been diagnosed with carpal tunnel syndrome through specific tests. However, if you have had wrist surgery or steroid injections for this condition, or if you have certain medical conditions like blood disorders or nerve issues, you may not be eligible. If you join, you can expect to receive one of the injection treatments and to be closely monitored for any changes in your symptoms. This study is currently looking for participants, and it's a great opportunity to help researchers learn more about effective treatments for carpal tunnel syndrome.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 20-80 year-old.
  • Diagnosis (carpal tunnel syndrome) was confirmed using an electrophysiological study.
  • Exclusion Criteria:
  • Previously undergone wrist surgery or steroid injection for CTS
  • Thrombocytopenia
  • Coagulopathy
  • Inflammation status
  • Polyneuropathy
  • Brachial plexopathy
  • Cervical radiculopathy
  • Autoimmune disease
  • Malignancy
  • Pregnancy
  • Thoracic outlet syndrome

About National Cheng Kung University Hospital

National Cheng Kung University Hospital is a leading academic medical institution in Taiwan, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources and expertise in various medical fields to facilitate groundbreaking studies that enhance patient care and medical knowledge. Committed to adhering to the highest ethical standards and regulatory guidelines, National Cheng Kung University Hospital fosters collaborations with researchers, healthcare professionals, and industry partners to drive the development of new therapies and improve health outcomes for diverse populations.

Locations

Tainan, , Taiwan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials